sibutramine has been researched along with Inappropriate ADH Syndrome in 1 studies
sibutramine: serotonin and norepinephrine transporter inhibitor; Meridia is tradename for sibutramine hydrochloride
Inappropriate ADH Syndrome: A condition of HYPONATREMIA and renal salt loss attributed to overexpansion of BODY FLUIDS resulting from sustained release of ANTIDIURETIC HORMONES which stimulates renal resorption of water. It is characterized by normal KIDNEY function, high urine OSMOLALITY, low serum osmolality, and neurological dysfunction. Etiologies include ADH-producing neoplasms, injuries or diseases involving the HYPOTHALAMUS, the PITUITARY GLAND, and the LUNG. This syndrome can also be drug-induced.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Esposito, P | 1 |
Rampino, T | 1 |
Gregorini, M | 1 |
Soccio, G | 1 |
Piotti, G | 1 |
Bedino, G | 1 |
Balenzano, CT | 1 |
Roscini, E | 1 |
Cosmai, L | 1 |
Portalupi, V | 1 |
Libetta, C | 1 |
Dal Canton, A | 1 |
1 other study available for sibutramine and Inappropriate ADH Syndrome
Article | Year |
---|---|
Severe symptomatic hyponatremia during sibutramine therapy: a case report.
Topics: Appetite Depressants; Body Mass Index; Cyclobutanes; Diagnosis, Differential; Emergency Service, Hos | 2008 |